GlassScriptPhysician profile
Brett A Armstrong
NPI 1710277249
$6,326.51
in general payments reported to CMS, 2019-2025
14 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,901 · 2020: $325 · 2021: $328 · 2022: $2,421 · 2023: $448 · 2024: $521 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,538.45 | 2019-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $382.27 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $115.26 | 2024 | Phasix Mesh |
| Lifenet Health | $56.35 | 2024 | Theragenesis Wound Matrix |
| Kerecis Limited | $34.82 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Karl Storz Endoscopy-America | $33.05 | 2023 | Image1 Connect |
| Smith+Nephew, INC. | $25.88 | 2024 | Grafix Pl |
| Merck Sharp & Dohme LLC | $25.37 | 2024 | Keytruda |
| Heron Therapeutics, INC. | $21.88 | 2024 | Zynrelef |
| Medela LLC | $21.34 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $20.08 | 2024 | Exparel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.92 | 2022 | |
| Ardelyx, INC. | $17.84 | 2023 | Ibsrela |
| Acera Surgical, INC. | $14.00 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.